Fig. 3 | British Journal of Cancer

Fig. 3

From: CE–MS-based urinary biomarkers to distinguish non-significant from significant prostate cancer

Fig. 3The alternative text for this image may have been generated using AI.

Receiver operating characteristics (ROC) analysis performed in the independent validation cohort, displaying the performance of the 19-biomarker panel for discriminating the case group (nSig = 48) from the control group (nnon-Sig = 232). ROC characteristics, such as area under the curve (AUC), 95% confidence intervals (CI), and p value are provided for the classification of Sig PCa patients

Back to article page